Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | Akebia Therapeutics, Inc. | Dahan Michel
(SVP, Chief Operating Officer) |
S | Common Stock | D | 8661 | $1.58 - $1.58 | $13,684 |
| 2024-02-29 | Akebia Therapeutics, Inc. | Hadas Nicole R.
(SVP, Chief Legal Officer) |
S | Common Stock | D | 5974 | $1.58 - $1.58 | $9,438 |
| 2024-02-29 | Akebia Therapeutics, Inc. | Butler John P.
(CEO and President) |
S | Common Stock | D | 46570 | $1.58 - $1.58 | $73,580 |
| 2024-02-29 | Akebia Therapeutics, Inc. | Burke Steven Keith
(SVP, Chief Medical Officer) |
S | Common Stock | D | 7169 | $1.58 - $1.58 | $11,327 |
| 2024-02-27 | Akebia Therapeutics, Inc. | Hadas Nicole R.
(SVP, Chief Legal Officer) |
S | Common Stock | D | 7411 | $1.52 - $1.52 | $11,264 |
| 2024-02-27 | Akebia Therapeutics, Inc. | Dahan Michel
(SVP, Chief Operating Officer) |
S | Common Stock | D | 10744 | $1.52 - $1.52 | $16,330 |
| 2024-02-27 | Akebia Therapeutics, Inc. | Burke Steven Keith
(SVP, Chief Medical Officer) |
S | Common Stock | D | 8367 | $1.52 - $1.52 | $12,717 |
| 2024-02-27 | Akebia Therapeutics, Inc. | Butler John P.
(CEO and President) |
S | Common Stock | D | 37733 | $1.52 - $1.52 | $57,354 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |